Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Market Research Report: Astex Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-26 00:41:16 - New Business research report from MarketLine is now available from Fast Market Research

Astex Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Astex Pharmaceuticals, Inc.
* Intelligence on Astex Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757149_astex_pharmaceuticals_inc_swot_strate ..

Highlights:

Astex Pharmaceuticals, Inc. (Astex or 'the company'), a subsidiary of Otsuka Pharmaceutical, discovers, develops and commercializes cancer therapies. The company operates in the US. Astex is headquartered in Dublin, California, and employed 136 people as of December 31, 2012. In October 2013, Otsuka Pharmaceutical, a wholly-owned subsidiary of Otsuka Holdings, completed the acquisition of Astex. Astex recorded revenues of $83.2 million during the financial year ended December 2012 (FY2012), an increase of 24.4% over FY2011. The operating loss of the company was $7.1 million in FY2012, as compared to an operating profit of $2.4 million in FY2011. The net profit was $8.2 million in FY2012, an increase of 49.1% over FY2011.

Reasons to Purchase:

* Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Astex Pharmaceuticals, Inc.: Company Overview
Astex Pharmaceuticals, Inc.: Overview and Key Facts
Astex Pharmaceuticals, Inc.: Overview
Astex Pharmaceuticals, Inc.: Key Facts
Astex Pharmaceuticals, Inc.: Key Employees
Astex Pharmaceuticals, Inc.: Key Employee Biographies
Astex Pharmaceuticals, Inc.: Major Products and Services
Astex Pharmaceuticals, Inc.: Company History
Astex Pharmaceuticals, Inc.: Management Statement
Astex Pharmaceuticals, Inc.: Locations and Subsidiaries
Astex Pharmaceuticals, Inc.: Key Competitors
Astex Pharmaceuticals, Inc.: Company Analysis
Astex Pharmaceuticals, Inc.: Business Description
Astex Pharmaceuticals, Inc.: SWOT Analysis
Astex Pharmaceuticals, Inc.: SWOT Overview
Astex Pharmaceuticals, Inc.: Strengths
Astex Pharmaceuticals, Inc.: Weaknesses
Astex Pharmaceuticals, Inc.: Opportunities
Astex Pharmaceuticals, Inc.: Threats
Astex Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Astex Pharmaceuticals, Inc.: Financial Deals Overview
Astex Pharmaceuticals, Inc.: Targets and Partners
Astex Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Astex Pharmaceuticals, Inc.: Advisors
Astex Pharmaceuticals, Inc.: Top Legal Advisors
Astex Pharmaceuticals, Inc.: Top Financial Advisors
Astex Pharmaceuticals, Inc.: Mergers and Acquisitions
Astex Pharmaceuticals, Inc.: Partnership
Astex Pharmaceuticals, Inc.: Private Equity and Ownership
Astex Pharmaceuticals, Inc.: Recent Developments
Astex Pharmaceuticals, Inc.: News and Events Summary
Astex Pharmaceuticals, Inc.: Corporate Governance
Astex Pharmaceuticals, Inc.: Financial Performance
Astex Pharmaceuticals, Inc.: Regulatory and Legal Events
Astex Pharmaceuticals, Inc.: Research & Development
Astex Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Astex Pharmaceuticals, Inc.: Key Facts
Table 2: Astex Pharmaceuticals, Inc.: Key Employees
Table 4: Astex Pharmaceuticals, Inc.: Key Competitors
Table 5: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Astex Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Astex Pharmaceuticals, Inc.: Targets and Partners
Table 9: Astex Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 10: Astex Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Astex Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Astex Pharmaceuticals, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 13: Astex Pharmaceuticals, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 14: Astex Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 15: Astex Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 16: Astex Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2009 - YTD*2013)
Table 17: Astex Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2009 - YTD*2013)
Table 18: Astex Pharmaceuticals, Inc.: News and Events Summary

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757149&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com